← Open Payments lookup

CAROLINE LEIBOWITZ: Open Payments

NPI 1114532173 · OAKHURST, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,790 in 253 payments from 23 companies in 2025. Trend: 2023 $2,086 · 2024 $1,984 · 2025 $3,790

Food & beverage: $3,790
CompanyPaymentsAmount
ABBVIE INC.45$675
Salix Pharmaceuticals, a division of Bausch Health US, LLC25$458
Janssen Biotech, Inc.25$452
Takeda Pharmaceuticals U.S.A., Inc.22$415
Madrigal Pharmaceuticals27$318
PFIZER INC.14$262
Aimmune Therapeutics, Inc.36$189
QOL Medical, LLC10$188
Ardelyx, Inc.9$171
GENZYME CORPORATION5$102

Products named: RINVOQ, TREMFYA, XIFAXAN, REZDIFFRA, ENTYVIO, ZENPEP, Sucraid, IBSRELA.

Industry payments across NJ — which companies pay providers there.